Provided by Tiger Trade Technology Pte. Ltd.

Evaxion Biotech A/S

3.07
-0.0034-0.11%
Volume:25.22K
Turnover:78.39K
Market Cap:25.46M
PE:-2.82
High:3.15
Open:3.10
Low:3.07
Close:3.07
52wk High:12.15
52wk Low:2.52
Shares:8.30M
Float Shares:5.53M
Volume Ratio:0.41
T/O Rate:0.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0886
EPS(LYR):-1.2027
ROE:-109.86%
ROA:-25.97%
PB:2.67
PE(LYR):-2.55

Loading ...

European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading

MT Newswires Live
·
Apr 13

European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

MT Newswires Live
·
Apr 09

Evaxion Biotech reports last patient visit in one-year extension of EVX-01 trial

TIPRANKS
·
Apr 07

Evaxion completes phase 2 EVX-01 trial extension; three-year data due H2 2026

Reuters
·
Apr 07

European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

MT Newswires Live
·
Apr 02

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
Mar 31

Evaxion to present AI-designed next-generation polio vaccine concepts at World Vaccine Congress

Reuters
·
Mar 30

European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading

MT Newswires Live
·
Mar 24

Evaxion Calls April 16, 2026 AGM to Expand Capital and Warrant Authorizations

TIPRANKS
·
Mar 19

Evaxion Biotech Sets April 16, 2026 Date for Annual General Meeting

TIPRANKS
·
Mar 19

Evaxion shareholders to vote on board authority for DKK 73.5 million convertible loan notes

Reuters
·
Mar 19

Notice to convene Evaxion’s Annual General Meeting

GlobeNewswire
·
Mar 19

Evaxion A/S Director Marianne Soegaard Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19

Evaxion A/S files initial beneficial ownership statement for Chief AI Officer Andreas Holm Mattsson

Reuters
·
Mar 19

Evaxion A/S files Form 3 initial beneficial ownership statement for Chief Scientific Officer Birgitte Rono

Reuters
·
Mar 19

Evaxion A/S Director Lars Holtug Files Initial Statement of Beneficial Ownership

Reuters
·
Mar 19

Evaxion A/S CEO Helen Katrina Tayton-Martin files initial beneficial ownership statement

Reuters
·
Mar 19

Evaxion to Present New AI-Driven Cancer Vaccine Data at AACR 2026

TIPRANKS
·
Mar 18

Evaxion to present two abstracts and attend AACR Oncology Industry Partnering event

Reuters
·
Mar 18

European Equities Traded in the US as American Depositary Receipts Higher Monday

MT Newswires Live
·
Mar 16